{"id":"https://openalex.org/W2113695682","doi":"https://doi.org/10.1200/jco.2004.02.101","title":"Reduction From Seven to Five Cycles of Intensive Induction Chemotherapy in Children With High-Risk Neuroblastoma","display_name":"Reduction From Seven to Five Cycles of Intensive Induction Chemotherapy in Children With High-Risk Neuroblastoma","publication_year":2004,"publication_date":"2004-12-15","ids":{"openalex":"https://openalex.org/W2113695682","doi":"https://doi.org/10.1200/jco.2004.02.101","mag":"2113695682","pmid":"https://pubmed.ncbi.nlm.nih.gov/15611504"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.02.101","doi":"https://doi.org/10.1200/jco.2004.02.101","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.02.101","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043729995","display_name":"Brian H. Kushner","orcid":"https://orcid.org/0000-0002-8916-0697","observed_orcids":["https://orcid.org/0000-0002-8916-0697"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian H. Kushner","raw_affiliation_strings":["From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY","Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034325765","display_name":"Kim Kramer","orcid":"https://orcid.org/0000-0002-3803-878X","observed_orcids":["https://orcid.org/0000-0002-3803-878X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kim Kramer","raw_affiliation_strings":["From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002140630","display_name":"Michael P. LaQuaglia","orcid":"https://orcid.org/0000-0002-7059-9851","observed_orcids":["https://orcid.org/0000-0002-7059-9851"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael P. LaQuaglia","raw_affiliation_strings":["From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105830310","display_name":"Shakeel I. Modak","orcid":"https://orcid.org/0000-0002-7280-1726","observed_orcids":["https://orcid.org/0000-0002-7280-1726"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shakeel Modak","raw_affiliation_strings":["From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031172839","display_name":"Karima Yataghene","orcid":"https://orcid.org/0000-0002-5223-6504","observed_orcids":["https://orcid.org/0000-0002-5223-6504"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karima Yataghene","raw_affiliation_strings":["From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034081882","display_name":"Nai\u2010Kong V. Cheung","orcid":"https://orcid.org/0000-0001-6323-5171","observed_orcids":["https://orcid.org/0000-0001-6323-5171"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nai-Kong V. Cheung","raw_affiliation_strings":["From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Departments of Pediatrics and Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":4.0266,"has_fulltext":false,"cited_by_count":138,"citation_normalized_percentile":{"value":0.93045731,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"22","issue":"24","first_page":"4888","last_page":"4892"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-risk-neuroblastoma","display_name":"high-risk neuroblastoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/pediatric-neuroblastoma","display_name":"pediatric neuroblastoma","score":0.7559999823570251},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.7990000247955322},{"id":"https://openalex.org/keywords/dose-intensive-chemotherapy","display_name":"dose-intensive chemotherapy","score":0.5509999990463257},{"id":"https://openalex.org/keywords/chemotherapy-reduction","display_name":"chemotherapy reduction","score":0.3720000088214874},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8650000095367432},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.996999979019165},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/anti-gd2-immunotherapy","display_name":"anti-GD2 immunotherapy","score":0.8550000190734863},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6380000114440918},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.8420000076293945},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.8519999980926514},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.934772253036499},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.7828243374824524},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.7523055076599121},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6739168167114258},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.6057848930358887},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.604873776435852},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5989894866943359},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5403606295585632},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5321806073188782},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5109252333641052},{"id":"https://openalex.org/C2776581026","wikidata":"https://www.wikidata.org/wiki/Q864868","display_name":"Bone marrow suppression","level":3,"score":0.493706077337265},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.47670477628707886},{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.45496779680252075},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005732","descriptor_name":"Gangliosides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.02.101","doi":"https://doi.org/10.1200/jco.2004.02.101","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.02.101","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:15611504","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15611504","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1117419297","display_name":null,"funder_award_id":"CA72868","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1516860519","display_name":"NOVEL COMBINATION THERAPY OF NEUROBLASTOMA","funder_award_id":"5r01ca061017-06","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1836322885","display_name":null,"funder_award_id":"CA61017","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5673822214","display_name":"INTRATHECAL RADIOIMMUNOTHERAPY OF CNS MALIGNANCIES","funder_award_id":"K08CA072868","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1826533514","https://openalex.org/W1864337426","https://openalex.org/W1940650862","https://openalex.org/W1970865970","https://openalex.org/W1974954809","https://openalex.org/W1982207252","https://openalex.org/W2033920171","https://openalex.org/W2039990819","https://openalex.org/W2046300584","https://openalex.org/W2049208274","https://openalex.org/W2096398040","https://openalex.org/W2138216545","https://openalex.org/W2164097016","https://openalex.org/W2164932761","https://openalex.org/W2179636545","https://openalex.org/W2216269393","https://openalex.org/W2228058953","https://openalex.org/W2256311673","https://openalex.org/W2257281028","https://openalex.org/W2327522594"],"related_works":["https://openalex.org/W2256395403","https://openalex.org/W2065700521","https://openalex.org/W2064921414","https://openalex.org/W2142707396","https://openalex.org/W2179636545","https://openalex.org/W4307370637","https://openalex.org/W1826533514","https://openalex.org/W2051406185","https://openalex.org/W23717296","https://openalex.org/W2086226581"],"abstract_inverted_index":{"PURPOSE:":[0],"We":[1,20],"previously":[2],"reported":[3],"a":[4,9,103,212,219],"high":[5],"response":[6],"rate":[7,214,221],"with":[8,16,25,47,218,236,267],"dose-intensive":[10],"chemotherapy":[11],"regimen":[12],"in":[13,81,131,144,168,171,262],"24":[14],"children":[15,46,266],"high-risk":[17,48,268],"neuroblastoma":[18],"(NB).":[19],"now":[21],"describe":[22],"similar":[23],"results":[24,178],"changes":[26],"that":[27,52],"reduce":[28],"toxicity":[29],"(fewer":[30],"cycles,":[31],"less":[32,194],"vincristine,":[33],"use":[34],"of":[35,105,119,134,153,174,215,252,265],"granulocyte":[36],"colony-stimulating":[37],"factor).":[38],"PATIENTS":[39],"AND":[40],"METHODS:":[41],"Eighty-seven":[42],"consecutive":[43],"newly":[44],"diagnosed":[45],"NB":[49],"underwent":[50],"induction":[51,109,254],"initially":[53],"had":[54],"seven":[55,223,245],"cycles":[56,123,210,251],"(57":[57],"patients)":[58],"but":[59],"was":[60,110,138,234],"later":[61],"limited":[62],"to":[63,113,259],"five":[64],"(30":[65],"patients).":[66,125],"Cycles":[67,89],"1,":[68],"2,":[69],"4,":[70,151],"and":[71,92,137,142,202,230],"6":[72],"used":[73,94],"cyclophosphamide":[74],"(140":[75],"mg/kg)/doxorubicin":[76],"(75":[77],"mg/m(2))/vincristine":[78],"(0.15":[79],"mg/kg":[80,87],"the":[82,120,237],"first":[83],"27":[84],"patients,":[85],"0.067":[86],"subsequently).":[88],"3,":[90],"5,":[91],"7":[93],"cisplatin":[95],"(200":[96],"mg/m(2))/etoposide":[97],"(600":[98],"mg/m(2)).":[99],"Tumor":[100],"resection":[101],"followed":[102],"minimum":[104],"three":[106,122,192],"cycles.":[107,224],"The":[108],"eventually":[111],"modified":[112],"include":[114],"anti-G(D2)":[115],"immunotherapy":[116],"after":[117],"each":[118],"last":[121],"(38":[124],"RESULTS:":[126],"Bone":[127],"marrow":[128],"disease":[129],"resolved":[130],"70":[132],"(91%)":[133],"77":[135],"patients":[136,242],"not":[139,205],"detected":[140],"pre-":[141],"postinduction":[143],"10":[145],"patients.":[146,176],"After":[147],"cycle":[148],"3":[149],"or":[150],"86%":[152],"primary":[154],"tumors":[155],"were":[156,227],"more":[157],"than":[158,195],"50%":[159],"smaller.":[160],"Postinduction":[161],"metaiodobenzylguanidine":[162],"scans":[163],"showed":[164],"normal":[165],"radiotracer":[166],"distribution":[167],"metastatic":[169],"sites":[170],"74":[172],"(87%)":[173],"85":[175],"Overall":[177],"were:":[179],"68":[180],"(79%)":[181],"complete/very":[182],"good":[183],"partial":[184,189],"responses":[185,190],"(CR/VGPR);":[186],"14":[187],"(16%)":[188],"(PR);":[191],"(3%)":[193],"PR;":[196],"one":[197,203],"(1%)":[198],"death":[199],"from":[200,222],"infection;":[201],"patient":[204],"assessable":[206],"for":[207],"response.":[208],"Five":[209,250],"yielded":[211],"CR/VGPR":[213,261],"83%,":[216],"compared":[217],"77%":[220],"Side":[225],"effects":[226],"myelosuppression,":[228],"mucositis,":[229],"hearing":[231],"deficits;":[232],"neurotoxicity":[233],"insignificant":[235],"lower":[238],"vincristine":[239],"dosage.":[240],"Four":[241],"(each":[243],"received":[244],"cycles)":[246],"developed":[247],"myelodysplasia/leukemia.":[248],"CONCLUSION:":[249],"this":[253],"regimen,":[255],"plus":[256],"surgery,":[257],"suffice":[258],"achieve":[260],"approximately":[263],"80%":[264],"NB.":[269]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}